FDA Grants Priority Tag to Bayer's Oncology Drug for First-Line NSCLC
BAYRY wins FDA priority review for sevabertinib in first-line HER2-mutant NSCLC, building momentum for the oral TKI.
Bayer Gets FDA Priority Review for Asundexian NDA in Stroke Prevention
BAYRY gains FDA Priority Review for asundexian NDA after phase III data showed a 26% cut in ischemic stroke risk without more major bleeding.
Bayer Aktiengesellschaft Backs Crop Science Targets as Seed Pipeline Gains Momentum
Bayer Aktiengesellschaft ETR: BAYN executives said the company's Crop Science division remains on track with a five-year plan centered on cost savings, margin expansion and a slate of product launches in seeds, traits and crop protection.
Bayer Net Profit Surges Driven by Growth in Agricultural Division
The group's net profit was aided by a gain from the sale of an antibiotics business and stronger underlying earnings at its agricultural division.
Bayer to Buy Eye-Drug Developer Perfuse Therapeutics for Up to $2.45 Billion
The German pharmaceutical-and-agricultural group said that the deal aims to complement its ophthalmology pipeline.
Bayer to buy Perfuse Therapeutics in up to $2.45 billion deal
Bayer said on Wednesday that it will buy biopharmaceutical company Perfuse Therapeutics to complement its ophthalmology pipeline.
Bayer Aktiengesellschaft (BAYRY) Shareholder/Analyst Call Transcript
Bayer Aktiengesellschaft (BAYRY) Shareholder/Analyst Call Transcript
Bayer shares slide after U.S. Supreme Court split over Bayer's fight against Roundup lawsuits
Shares in chemicals giant Bayer fell as much as 6.5% on Tuesday after the U.S. Supreme Court appeared split over what view it will form in Bayer's fight against Roundup lawsuits.
US Supreme Court hears Bayer's fight against Roundup lawsuits
The U.S. Supreme Court is set on Monday to consider Bayer AG's effort to shut down thousands of lawsuits accusing the company of failing to warn users that the active ingredient in its Roundup weedkiller causes cancer.
Explainer: What does Bayer's US Supreme Court case mean for the thousands of Roundup lawsuits?
The U.S. Supreme Court hears arguments on Monday in Bayer's bid to limit thousands of lawsuits alleging that the German company's Roundup weedkiller causes cancer in a case that is one part of sprawling yearslong litigation over the product.
US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims
A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its multibillion-dollar drug cuts the risk of death from prostate cancer in half.
Bayer Advances AB-1002 Study, Highlights Pharma Growth Strategy
Bayer advances AB-1002 after AskBio completes mid-stage study enrollment, as its Pharma strategy and pipeline milestones drive long-term growth outlook.
